- $5.96bn
- $6.74bn
- $3.77bn
- 97
- 61
- 55
- 82
Annual income statement for Qorvo, fiscal year end - March 30th, USD millions except per share, conversion factor applied.
2020 March 28th | 2021 April 3rd | 2022 April 2nd | 2023 April 1st | 2024 March 30th | |
|---|---|---|---|---|---|
| Period Length: | 52 W | 53 W | 52 W | 52 W | 52 W |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3,239 | 4,015 | 4,646 | 3,569 | 3,770 |
| Cost of Revenue | |||||
| Gross Profit | 1,356 | 1,884 | 2,286 | 1,297 | 1,512 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 2,906 | 3,173 | 3,420 | 3,394 | 3,676 |
| Operating Profit | 333 | 842 | 1,226 | 175 | 93.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 395 | 807 | 1,181 | 125 | 73.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 334 | 734 | 1,033 | 103 | -70.3 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 334 | 734 | 1,033 | 103 | -70.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 334 | 734 | 1,033 | 103 | -70.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 4.4 | 7.2 | 9.99 | 2.29 | 1.59 |